ASX-listed oOh!media bids surge to $850M
The takeover battle for outdoor advertising giant oOh!media (ASX:OML) intensifies as revised private equity bids converge at up to $1.60 per share.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
The takeover battle for outdoor advertising giant oOh!media (ASX:OML) intensifies as revised private equity bids converge at up to $1.60 per share.
The Digital Asset Market Clarity Act has been placed on the US Senate Legislative Calendar, with lawmakers racing to secure a floor vote before the 119th Congress concludes and the legislative process potentially resets.
ASX (ASX:ASX) faces a $20.5 million fine after admitting to misleading the market over its failed CHESS upgrade project.
The CLARITY Act is unlikely to reach final passage by 4 July, delaying White House hopes of signing a major US crypto bill on America’s 250th birthday.
Kalshi, Crypto.com, Polymarket and other prediction market platforms have jointly filed a lawsuit in Kentucky state court to block a new 14.25% tax on transaction fees.
Disc Medicine (NASDAQ:IRON) disclosed positive, updated clinical data across its core hematology pipeline during the 2026 European Hematology Association (EHA) Annual Meeting in Stockholm, Sweden.
Cogent Biosciences (NASDAQ:COGT) announced detailed clinical results from its registration-directed APEX trial evaluating its investigational precision therapy, bezuclastinib, in patients with advanced systemic mastocytosis (AdvSM).
MBX Biosciences (NASDAQ:MBX) announced detailed results from its 12-week Avail Phase 2 clinical trial and new one-year data from an ongoing open-label extension study evaluating its investigational endocrine therapy, canvuparatide.
Vertiv Holdings (NYSE:VRT) has finalized its acquisition of ThermoKey, a specialized European manufacturer of heat-rejection and heat-exchange systems, directly expanding its critical digital infrastructure portfolio.
HF Foods Group (NASDAQ:HFFG) announced that its Board of Directors has adopted a limited-duration stockholder rights plan, commonly known as a "poison pill," intended to protect corporate assets against potential hostile takeover attempts.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy